What Level of Luteinizing Hormone (LH) Is Normal?

Normal luteinizing hormone levels depend heavily on who you are and when the blood is drawn. In women of reproductive age, LH can range from roughly 1 to 12 IU/L during most of the menstrual cycle, then spike to anywhere from about 20 to over 100 IU/L around ovulation. In men, the typical range sits around 1.5 to 9 IU/L, and in children before puberty, levels are usually well under 1 IU/L. These numbers shift with age, body composition, medications, and even the time of day, which is part of why a single LH result can be surprisingly hard to interpret without context.

What LH Does and Why It Fluctuates

LH is one of two gonadotropic hormones released by the pituitary gland, the other being follicle-stimulating hormone (FSH). Both are triggered by a signal from the hypothalamus called gonadotropin-releasing hormone, or GnRH, which comes in rhythmic pulses rather than a steady stream.¹ The speed and strength of those GnRH pulses determine how much LH (versus FSH) gets released at any given moment. Fast pulses favor LH; slower pulses favor FSH. This pulsatile pattern means LH doesn’t hold steady in your blood. It rises and falls throughout the day in small bursts, which is one reason a single blood draw only captures a snapshot.

In women, LH has two main jobs: it helps follicles in the ovary mature during the first half of the cycle, and a dramatic midcycle LH surge triggers ovulation. After the egg is released, LH supports the corpus luteum, which produces progesterone to sustain a potential pregnancy. In men, LH acts on Leydig cells in the testes, directly stimulating them to produce testosterone. Without LH signaling, testosterone production drops and sperm development suffers.² LH binds to a receptor on the Leydig cell surface, which kicks off an internal signaling chain involving calcium and a molecule called cAMP that ultimately ramps up testosterone synthesis.³

Normal Ranges in Women Across the Menstrual Cycle

The reference range that appears on your lab report usually breaks the menstrual cycle into phases, because LH behaves so differently in each one. During the follicular phase (from the start of menstruation until just before ovulation), LH generally runs between about 1 and 12 IU/L. In the luteal phase (after ovulation until the next period), the range is similar. The standout moment is the midcycle surge, when LH can leap to 20 IU/L or above, sometimes exceeding 100 IU/L. This surge lasts roughly 24 to 48 hours and is what triggers the ovary to release an egg.

After menopause, the ovaries stop producing meaningful amounts of estrogen and progesterone. Without that feedback telling the pituitary to ease off, LH and FSH both climb and stay elevated. Postmenopausal LH levels commonly sit between about 15 and 65 IU/L, though exact cutoffs vary by laboratory. This is a normal physiological shift, not a sign of disease. The same pattern appears in premature ovarian insufficiency, where ovarian function declines before age 40 and LH rises as a consequence.⁴

Normal Ranges in Men and How They Change With Age

For adult men, LH reference ranges are typically around 1.5 to 9 IU/L. These numbers are more stable day to day than in women because there is no monthly cycle creating dramatic peaks and valleys. That said, LH in men isn’t static over a lifetime. Research tracking older men over multiple years has shown that both LH and FSH tend to rise as men age, while testosterone gradually declines.⁵ In one longitudinal study, about 10% of healthy older men had LH levels above the normal range at some point during follow-up.

Cross-sectional data paint a similar picture: adult LH and FSH levels settle after about age 16, then start creeping upward around the fifth decade of life. The increase in men, though, is relatively modest compared to the dramatic jump women experience at menopause, because male gonadal function declines gradually rather than shutting down abruptly.⁶ A mildly elevated LH in an older man, combined with a low-normal testosterone, might just reflect the natural aging of the testes rather than a disease process.

LH in Children and Puberty

Before puberty, both boys and girls have very low LH levels, often below the detection limit of standard assays. The pituitary is essentially quiet on the gonadotropin front. As puberty approaches, the GnRH pulse generator in the hypothalamus begins to awaken, initially during sleep. In girls, researchers have found that a sleep-time peak LH of about 1.3 IU/L or higher is a sensitive marker that puberty has begun, while a threshold around 2.1 IU/L is highly specific for it.⁷

Clinicians sometimes use stimulation tests when they suspect puberty is too early (precocious) or too late (delayed). In these tests, a GnRH-like drug is given and then LH is measured an hour later. A stimulated LH above roughly 3 to 5 IU/L generally confirms that the puberty machinery has switched on. These cutoffs matter clinically because a child with breast development and a prepubertal LH might have a benign variant rather than true central precocious puberty, and treatment decisions hinge on that distinction.

When LH Is Too High

Elevated LH relative to FSH is one of the hallmarks of polycystic ovary syndrome (PCOS), particularly in lean women. The underlying problem appears to involve disrupted signaling in the hypothalamus, where kisspeptin neurons fire in abnormal patterns, leading to overly fast GnRH pulses that favor LH over FSH.⁸ This tilt toward LH can stimulate excess androgen production in the ovaries, contributing to symptoms like irregular periods, acne, and excess hair growth. Not all women with PCOS show a raised LH-to-FSH ratio, though. In women with PCOS who also carry significant excess weight, insulin resistance tends to push LH levels down somewhat, which can mask the classic ratio.

Outside of PCOS, high LH often signals that the gonads themselves aren’t working well. When the ovaries or testes underperform, the pituitary ramps up LH production in an attempt to compensate. In women, this shows up in premature ovarian insufficiency and menopause. In men, a high LH paired with low testosterone points to primary hypogonadism, meaning the testes rather than the brain are the problem. Causes can range from genetic conditions to prior chemotherapy, infections, or injury.

When LH Is Too Low

Low LH usually traces back to the brain side of the equation. The most common scenario in younger women is functional hypothalamic amenorrhea, which accounts for roughly 30% of cases where menstrual periods stop for reasons other than pregnancy or menopause.⁹ In this condition, the hypothalamus slows or stops its GnRH pulses, which in turn shuts down LH and FSH release from the pituitary. The usual triggers are significant weight loss, intense exercise, or chronic psychological stress, and often a combination of all three.¹⁰

Less commonly, structural problems with the pituitary itself (tumors, prior surgery, radiation, or conditions like hemochromatosis) can reduce LH production. In men, low LH with low testosterone is termed secondary hypogonadism: the testes could produce testosterone if they received the signal, but the pituitary isn’t sending it. This distinction matters because the treatment approach differs. A man with primary hypogonadism (high LH, low testosterone) typically receives testosterone replacement, while a man with secondary hypogonadism might be treated with agents that stimulate his own pituitary, especially if preserving fertility is a goal.

Medications That Alter LH Levels

Hormonal contraceptives are probably the most widespread cause of suppressed LH. Combined oral contraceptive pills deliver synthetic estrogen and progestin, which tell the hypothalamus and pituitary that plenty of sex steroids are already circulating, so there’s no need to produce LH. Studies have shown that LH levels were significantly decreased in about three-quarters of women using combined pills, and the pituitary’s LH response to stimulation testing was also blunted in about 80% of users.¹¹ Research has also confirmed that this suppression is a direct effect of the pills on the pituitary, and that progestin-only formulations tend to have a milder effect.¹²

Anabolic steroids and exogenous testosterone work in a similar way in men: the extra testosterone feeds back to the brain, suppressing both LH and FSH, which is why steroid use often leads to shrunken testes and impaired fertility. On the treatment side, fertility medications like clomiphene citrate and letrozole work partly by blocking estrogen feedback, which causes LH to rise and can help trigger ovulation. Recombinant LH itself is sometimes used in assisted reproduction. Clinical trials have found that a single dose of recombinant human LH can trigger final follicular maturation during in vitro fertilization, performing comparably to the traditional agent (urinary hCG) with potentially fewer side effects.¹³

Why a Single LH Test Can Be Misleading

Because LH is secreted in pulses, a blood draw at one moment might catch a peak, and a draw thirty minutes later might catch a trough. This built-in variability can make individual results look confusingly high or low. Studies of women with PCOS, for example, have documented that LH pulse frequency slows at night, with the longest gap between pulses occurring in the early morning hours, while the highest average LH levels tend to appear in the late afternoon.¹⁴ Even in healthy individuals, this circadian pattern means the time of your blood draw introduces some noise.

Clinicians work around this in a few ways. Often they will look at LH together with FSH, estrogen, testosterone, and other markers rather than interpreting LH in isolation. For borderline or confusing results, a repeat blood draw on a different day or a stimulation test can help clarify the picture. In pediatric cases, where the differences between prepubertal and early pubertal LH overlap with assay sensitivity limits, providers may rely on a GnRH stimulation test rather than a random blood draw to get a definitive answer.

The Genetic Variant That Can Fool Lab Tests

There’s a common genetic variant of LH that alters the hormone’s structure just enough to affect how some laboratory tests detect it. This variant, caused by two point mutations in the gene for the LH beta-subunit, is found in populations worldwide and occurs frequently enough to be clinically relevant.¹⁵ People who carry one or two copies of this variant are generally healthy, but the altered LH molecule behaves slightly differently: it has modestly changed biological activity and is cleared from the bloodstream more quickly than the common form.

The practical problem arises because some laboratory assays use antibodies that don’t recognize this variant, producing an artificially low LH reading even though the person’s true LH production is normal. Other assays that target a different part of the molecule measure it just fine.¹⁶ If you’ve ever had an unexpectedly low LH result that doesn’t match the rest of your clinical picture, this variant is one possible explanation. It’s rarely tested for routinely, but endocrinologists who are aware of it may request a different assay platform if the initial result seems inconsistent.

Home Ovulation Tests and What They Measure

Over-the-counter ovulation predictor kits detect LH in urine, not blood, and they’re designed to catch the midcycle surge rather than give you an exact number. Most kits use a threshold around 25 mIU/mL as the cutoff for a positive result. A recent comparison of five commercially available one-step kits found that their overall accuracy, defined as agreement with a blood LH measurement, ranged from about 92% to 97% depending on the brand.¹⁷ Sensitivity for catching a true surge was more variable, ranging from about 38% to 77% across the kits tested.

That gap between accuracy and sensitivity is worth understanding. High accuracy means the kit usually agrees with the blood test overall (including all the days when LH is low and the test should be negative). Sensitivity, though, tells you how often the kit catches a genuine surge, and that number was lower. In practical terms, a negative home test doesn’t guarantee you aren’t surging; you may have caught a brief dip in urinary LH, or the specific kit’s antibody threshold may be slightly too high for your personal surge level. Testing at the same time each day and avoiding excessive fluid intake beforehand can help, but these kits are best used as a general timing tool rather than a definitive diagnostic.

How Body Weight and Metabolism Affect LH

Body fat appears to influence LH secretion in measurable ways, especially during adolescence. Research in adolescent girls found that higher body fat percentage predicted faster LH pulse frequency and lower overall LH output. Fatness and insulin levels together predicted a weaker LH response to GnRH stimulation.¹⁸ The relationship is likely mediated through insulin and related metabolic signals (like IGF-1), which appear to modulate hypothalamic GnRH pulse patterns.

This metabolic connection helps explain a few clinical observations. In PCOS, insulin resistance is thought to amplify androgen production partly by altering LH dynamics. In women who lose significant weight or have very low body fat from intense training, LH secretion can shut down altogether, as seen in hypothalamic amenorrhea. And in men, obesity is associated with lower testosterone and variable changes in LH: some obese men have low LH (suggesting central suppression), while others have normal or mildly elevated LH (suggesting their testes are struggling despite adequate signaling). The relationship between body composition and LH is bidirectional and messy, which is part of why clinicians look at the full hormonal panel rather than interpreting LH by itself.

LH in Fertility Treatment

In assisted reproduction, LH plays a dual role as both a diagnostic marker and a therapeutic tool. Before starting treatment, LH levels help categorize the cause of infertility. Low LH with low FSH points to a hypothalamic or pituitary problem, which may respond well to pulsatile GnRH therapy or injectable gonadotropins. High LH relative to FSH can signal PCOS, where the treatment approach often involves suppressing the overactive LH drive before stimulating follicle growth in a more controlled way.

During ovarian stimulation for IVF, most protocols use GnRH agonists or antagonists to temporarily suppress the patient’s own LH, preventing a premature surge that would trigger ovulation before the eggs can be retrieved. A small amount of LH activity is still needed, though, because the developing follicles require some LH to produce the estrogen precursors that support egg maturation. For women whose own LH is deeply suppressed (particularly those using high-dose GnRH antagonist protocols or those with hypogonadotropic hypogonadism), adding a low dose of recombinant LH or low-dose hCG to the stimulation regimen can improve outcomes. The balancing act between too much and too little LH during a stimulation cycle is one of the more nuanced aspects of reproductive endocrinology.

Recombinant LH has also found a role as a trigger for final egg maturation. Traditional protocols use hCG for this purpose because it mimics LH’s action on the same receptor, but hCG lingers in the body much longer than natural LH, which can overstimulate the ovaries in women at high risk for ovarian hyperstimulation syndrome. Clinical data have shown that recombinant LH can accomplish the same goal with a potentially better safety profile, although its shorter half-life means the timing window is tighter.¹³